What is the share price of Fortis Healthcare Ltd (FORTIS) today?
The share price of FORTIS as on 5th October 2026 is ₹774.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Fortis Healthcare Ltd (FORTIS) share?
The past returns of Fortis Healthcare Ltd (FORTIS) share are- Past 1 week: -11.96%
- Past 1 month: -13.89%
- Past 3 months: -17.32%
- Past 6 months: -1.30%
- Past 1 year: -20.71%
- Past 3 years: 130.81%
- Past 5 years: 195.31%
What are the peers or stocks similar to Fortis Healthcare Ltd (FORTIS)?
The peers or stocks similar to Fortis Healthcare Ltd (FORTIS) include:What is the dividend yield % of Fortis Healthcare Ltd (FORTIS) share?
The current dividend yield of Fortis Healthcare Ltd (FORTIS) is 0.13.What is the market cap of Fortis Healthcare Ltd (FORTIS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fortis Healthcare Ltd (FORTIS) is ₹59264.21 Cr as of 5th October 2026.What is the 52 week high and low of Fortis Healthcare Ltd (FORTIS) share?
The 52-week high of Fortis Healthcare Ltd (FORTIS) is ₹1104.30 and the 52-week low is ₹745.35.What is the PE and PB ratio of Fortis Healthcare Ltd (FORTIS) stock?
The P/E (price-to-earnings) ratio of Fortis Healthcare Ltd (FORTIS) is 56.89. The P/B (price-to-book) ratio is 5.83.Which sector does Fortis Healthcare Ltd (FORTIS) belong to?
Fortis Healthcare Ltd (FORTIS) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Fortis Healthcare Ltd (FORTIS) shares?
You can directly buy Fortis Healthcare Ltd (FORTIS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Fortis Healthcare Ltd
FORTIS Share Price
NSE₹774.201.33% (-10.45)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
FORTIS Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
FORTIS Performance & Key Metrics
FORTIS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 56.56 | 5.83 | 0.13% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 45.78 | 5.74 | 0.50% |
90%
Analysts have suggested that investors can buy this stock
from 20 analysts
Price Upside
Earnings Growth
Rev. Growth
FORTIS Company Profile
Fortis Healthcare Limited is an integrated healthcare delivery service provider. The Company is engaged in establishing, administering hospitals, diagnostic centers and research centers.
APOLLOHOSP
PE Ratio
60.23
60.23
1Y Return
8.59%
8.59%
Buy Reco %
86.67
86.67
MAXHEALTH
PE Ratio
63.49
63.49
1Y Return
15.02%
15.02%
Buy Reco %
83.33
83.33
MANIPALHOS
PE Ratio
102.60
102.60
1Y Return
4.06%
4.06%
Buy Reco %
66.67
66.67
PE Ratio
159.20
159.20
1Y Return
12.39%
12.39%
Buy Reco %
91.67
91.67
MEDANTA
PE Ratio
65.52
65.52
1Y Return
4.02%
4.02%
Buy Reco %
89.47
89.47
FORTIS Sentiment Analysis
FORTIS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
FORTIS Stock Summary · August 2026
Management struck a constructive but measured tone, saying the quarter marked a steady start to FY27 with solid growth across both hospitals and diagnostics. Consolidated revenue rose 17.5% year over year to INR 2,545 crores, while operating EBITDA before ESOP expenses increased 15.8% to INR 568 crores, even as the margin eased slightly to 22.3% from 22.6%. In hospitals, occupancy held at 69% and occupied beds increased 17% to 3,418, supported by acquisitions and higher utilization, while ARPOB improved 2.6%; management also noted that newer assets in Punjab, Bengaluru and Delhi NCR diluted margins temporarily, though like-for-like performance remained broadly stable. Growth was led by core specialties and a richer profitability mix, with 14 facilities now generating EBITDA margins above 20%. Management emphasized expansion through brownfield and greenfield additions, oncology investments, and robotics, while keeping debt at a manageable 1.01x net debt-to-EBITDA. Looking ahead, it reiterated a 25% EBITDA margin target over the next two years despite ESOP costs, and guided diagnostics to about 12% to 13% revenue growth with margins of 24% to 25%.
FORTIS Stock Growth Drivers
FORTIS Stock Growth Drivers
8Strong Consolidated Revenue and EBITDA Growth
The company delivered a solid start to FY27 with consolidated revenue rising 17.5% year over
Hospital Network Growth and Specialty-Led Demand
The hospital business showed strong underlying momentum, with revenue growth of 19% and steady occupancy
FORTIS Stock Challenges
FORTIS Stock Challenges
3Hospital margin pressure from ESOP, legal costs, and doubtful debt provisions
Hospital profitability was pressured by multiple near-term cost and credit headwinds. Segment EBITDA margin declined
Delayed collections increasing credit risk and working-capital drag
Collections from government payors and certain TPAs have slowed, leading to a higher provision for
FORTIS Forecast
FORTIS Forecasts
Price
Revenue
Earnings
FORTIS Share Price Forecast
FORTIS Share Price Forecast
2026
Current
₹784.65
Baseline
Forecast for Oct 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹784.65
Baseline
Forecast for Oct 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
FORTIS Company Revenue Forecast
FORTIS Company Revenue Forecast
2026
Current
₹9.61
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹9.61
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
FORTIS Stock EPS (Earnings Per Share) Forecast
FORTIS Stock EPS (Earnings Per Share) Forecast
2026
Current
₹13.80
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹13.80
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
FORTIS
FORTIS
Income
Balance Sheet
Cash Flow
Quarterly Normal View
FORTIS Income Statement
FORTIS Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,803.14 | 1,872.70 | 2,005.86 | 1,975.01 | 2,031.64 | 2,197.67 | 2,381.23 | 2,276.83 | 2,375.28 | 2,573.41 | ||||||||||
Operating & Other expenses | 1,404.84 | 1,516.38 | 1,613.33 | 1,553.14 | 1,625.30 | 1,676.05 | 1,775.11 | 1,805.27 | 1,844.83 | 2,007.91 | ||||||||||
EBITDA | 398.30 | 356.32 | 392.53 | 421.87 | 406.34 | 521.62 | 606.12 | 471.56 | 530.45 | 565.50 | ||||||||||
| Depreciation/Amortization | 92.23 | 91.00 | 95.05 | 97.33 | 102.23 | 101.48 | 105.84 | 120.14 | 121.97 | 121.88 | ||||||||||
| PBIT | 306.07 | 265.32 | 297.48 | 324.54 | 304.11 | 420.14 | 500.28 | 351.42 | 408.48 | 443.62 | ||||||||||
| Interest & Other Items | 34.69 | 35.27 | 36.43 | 45.15 | 67.56 | 69.57 | 74.88 | 85.74 | 84.28 | 80.44 | ||||||||||
| PBT | 271.38 | 230.05 | 261.05 | 279.39 | 236.55 | 350.57 | 425.40 | 265.68 | 324.20 | 363.18 | ||||||||||
| Taxes & Other Items | 92.65 | 64.09 | 84.59 | 31.49 | 52.66 | 90.29 | 103.48 | 71.95 | 58.35 | 96.79 | ||||||||||
| Net Income | 178.73 | 165.96 | 176.46 | 247.90 | 183.89 | 260.28 | 321.92 | 193.73 | 265.85 | 266.39 | ||||||||||
| EPS | 2.37 | 2.20 | 2.34 | 3.28 | 2.44 | 3.45 | 4.26 | 2.57 | 3.52 | 3.53 |
FORTIS Company Updates
FY 2027FY 2027
Investor Presentation
Aug 6PDF
FORTIS Stock Peers
FORTIS Past Performance & Peer Comparison
FORTIS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Fortis Healthcare Ltd | 56.89 | 5.83 | 0.13% |
| Apollo Hospitals Enterprise Limited | 60.23 | 11.72 | 0.25% |
| Max Healthcare Institute Limited | 63.49 | 8.52 | 0.21% |
| Manipal Health Enterprises Limited | 102.60 | 10.40 | — |
FORTIS Stock Price Comparison
Compare FORTIS with any stock or ETFCompare FORTIS with any stock or ETF
FORTIS
FORTIS Holdings
FORTIS Shareholdings
FORTIS Promoter Holdings Trend
FORTIS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
FORTIS Institutional Holdings Trend
FORTIS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
FORTIS Shareholding Pattern
FORTIS Shareholding Pattern
FORTIS Shareholding History
FORTIS Shareholding History
Foreign Institutions
Mutual Funds Invested in FORTIS
Mutual Funds Invested in FORTIS
No mutual funds holding trends are available
Top 5 Mutual Funds holding Fortis Healthcare Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 4.9124% | Percentage of the fund’s portfolio invested in the stock 2.69% | Change in the portfolio weight of the stock over the last 3 months -0.39% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 10/81 (-4) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 4.2997% | Percentage of the fund’s portfolio invested in the stock 3.58% | Change in the portfolio weight of the stock over the last 3 months -0.40% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 1/74 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.3019% | Percentage of the fund’s portfolio invested in the stock 2.61% | Change in the portfolio weight of the stock over the last 3 months -0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 5/104 (-3) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing FORTIS stock
smallcases containing FORTIS stock
Looks like this stock is not in any smallcase yet.
FORTIS Events
FORTIS Events
FORTIS Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
FORTIS Dividend Trend
No dividend trend available
FORTIS Upcoming Dividends
FORTIS Upcoming Dividends
No upcoming dividends are available
FORTIS Past Dividends
FORTIS Past Dividends
Cash Dividend
Ex DateEx DateJul 24, 2026
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 24, 2026
Cash Dividend
Ex DateEx DateJul 25, 2025
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 25, 2025
Cash Dividend
Ex DateEx DateJul 24, 2024
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 24, 2024
Cash Dividend
Ex DateEx DateJul 20, 2023
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 20, 2023
FORTIS Stock News & Opinions
FORTIS Stock News & Opinions
Articles & Videos
Corporate
Corporate
Fortis Healthcare will halt share trading October 1st pending financial results declarationFortis Healthcare Limited will close its trading window for share transactions from October 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter and half year ended September 30, 2026, in accordance with its insider trading policy.
1 week agoCapital Market - Live
Earnings
Earnings
Fortis Healthcare Ltd consolidated sales up 7.63% on year in Q2FY2026Fortis Healthcare Ltd share price inched up 1.02% to Rs 935.0 after the company's net profit saw a mild growth of 0.59% to Rs 272.8 crore, while revenue from operations improved marginally 7.63% to Rs 2545.03 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.11 lakh crore, rising 5.20%. It has edged up by 13.41% over last one week and rallied by 31.33% in last one month while the market capitalization of Fortis Healthcare Ltd has slipped by 1.42% and 1.80% in the same period respectively. Profit before tax (PBT) of Fortis Healthcare Ltd stood at Rs 363.18 crore in Q2 FY26, gaining 3.60% year-on-year, and climbing 12.02% quarter-on-quarter. EBITDA came in at Rs 523 crore, easing 9.97% YoY and declining 1.00% sequentially. Total expenses saw a slight increase of 8.98% to Rs 2129.79 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 585.57 crore, increasing 12.45% YoY, while employee benefits expense was at Rs 404.43 crore, soaring 19.06% YoY. For the TTM ended FY26, revenue from operations rose 17.28% to Rs 9127.84 crore, while net profit soared by 31.48% to Rs 1064.19 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 158382% to Rs 2034.32 crore, and PBT witnessed a strong rise of 35.63% to Rs 1365.85 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 1601.46 crore in FY26, as against Rs 1423.93 crore in FY25. Fortis Healthcare Ltd headed higher 6.71% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.64% during the same period.
1 month agoCapital Market - Live
Corporate
Corporate
Fortis Healthcare to review quarterly results at board meeting on August 6, 2026Fortis Healthcare Limited will hold a board meeting on Thursday, August 06, 2026, to consider and approve the unaudited financial results (standalone & consolidated) for the quarter ended June 30, 2026, according to a regulatory filing. The company also announced that the trading window for dealing in securities will remain closed until August 08, 2026, following a previous announcement on June 24, 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Fortis Healthcare fixes record date for final dividendFortis Healthcare has fixed 24 July 2026 as record date for payment of final dividend for FY 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Fortis Healthcare to hold AGMFortis Healthcare announced that the Annual General Meeting(AGM) of the company will be held on 11 August 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Board of Fortis Healthcare recommends final dividendFortis Healthcare announced that the Board of Directors of the Company at its meeting held on 22 May 2026, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.
4 months agoCapital Market - Live
Earnings
Earnings
Fortis Healthcare consolidated net profit rises 44.57% in the March 2026 quarterNet profit of Fortis Healthcare rose 44.57% to Rs 265.85 crore in the quarter ended March 2026 as against Rs 183.89 crore during the previous quarter ended March 2025. Sales rose 17.81% to Rs 2364.67 crore in the quarter ended March 2026 as against Rs 2007.20 crore during the previous quarter ended March 2025. For the full year,net profit rose 34.56% to Rs 1041.78 crore in the year ended March 2026 as against Rs 774.21 crore during the previous year ended March 2025. Sales rose 17.28% to Rs 9127.84 crore in the year ended March 2026 as against Rs 7782.75 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales2364.672007.20 18 9127.847782.75 17 OPM %22.5121.70 -22.8420.40 - PBDT458.66392.35 17 1837.521481.99 24 PBT336.69290.12 16 1388.091096.38 27 NP265.85183.89 45 1041.78774.21 35 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Fortis Healthcare to discuss resultsFortis Healthcare will hold a meeting of the Board of Directors of the Company on 22 May 2026.
4 months agoCapital Market - Live
Earnings
Earnings
Fortis Healthcare consolidated net profit declines 21.85% in the December 2025 quarterNet profit of Fortis Healthcare declined 21.85% to Rs 193.73 crore in the quarter ended December 2025 as against Rs 247.90 crore during the previous quarter ended December 2024. Sales rose 17.46% to Rs 2265.01 crore in the quarter ended December 2025 as against Rs 1928.26 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales2265.011928.26 17 OPM %22.3219.45 - PBDT431.73352.92 22 PBT311.59255.59 22 NP193.73247.90 -22 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Fortis Healthcare schedules board meetingFortis Healthcare will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 17.64%, vs industry avg of 17.91%
Over the last 5 years, market share decreased from 9.69% to 9.34%